OrbiMed Capital GP IV LLC, Director, 10% Owner at Anthera Pharmaceuticals Inc (ANTH), sold 60,000 shares at $7.14 ($417K) on 2011-11-11, disclosed to the SEC on 2011-11-15.
Open-market sale of $417k ANTH by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.14 | 5,000 | $36K | 8.6% |
| 2 | $6.95 | 5,000 | $35K | 8.3% |
| 3 | $6.93 | 50,000 | $347K | 83.1% |
| Total | $6.95 avg | 60,000 | $417K | 100% |
| Filing → |
| BOLD | SELL | 2018-03-12 | $10.2M | — | Filing → |
| BOLD | SELL | 2017-09-11 | $112K | — | Filing → |
| OTIC | SELL | 2015-11-24 | $5.7M | — | Filing → |